Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Mutation research

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mrfmmm.2015.05.002PMID 26073472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival

  2013cited by this paper
• Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma

  2012cited by this paper
• Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas

  2012cited by this paper
• Prognostic significance of aberrant gene methylation in gastric cancer.

  2012cited by this paper
• Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.

  2012cited by this paper
• The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.

  2011cited by this paper
• DNA methylation biomarkers in serum for gastric cancer screening.

  2010cited by this paper
• 14-3-3 Mediated regulation of the tumor suppressor protein, RASSF1A

  2010cited by this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• DNA methylation based biomarkers in non-invasive cancer screening.

  2010cited by this paper
• Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

  2009cited by this paper
• Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis.

  2009cited by this paper
• Gastric oncology: an update

  2009cited by this paper
• Detection of promoter hypermethylation of the CpG island of E-cadherin in gastric cardiac adenocarcinoma

  2009cited by this paper
• Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.

  2008cited by this paper
• DNA methylation: a marker for carcinogen exposure and cancer risk

  2008cited by this paper
• Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.

  2007cited by this paper
• Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China

  2007cited by this paper
• Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.

  2007cited by this paper
• Aberrant DNA Methylation in Non-Neoplastic Gastric Mucosa of H. Pylori Infected Patients and Effect of Eradication

  2007cited by this paper
• Aberrant Methylation of Multiple Genes in Gastric Carcinomas

  2007cited by this paper
• Molecular mechanism of stomach carcinogenesis

  2005cited by this paper
• DNA methylation and gene silencing in cancer

  2005cited by this paper
• RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics

  2004cited by this paper
• Concerted promoter hypermethylation of hMLH1, p16INK4A, and E‐cadherin in gastric carcinomas with microsatellite instability

  2003cited by this paper
• Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.

  2003cited by this paper
• The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation

  2002cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Molecular Characterization of Undifferentiated-Type Gastric Carcinoma

  2001cited by this paper
• Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

  2001cited by this paper
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

  2001cited by this paper
• The sequential accumulation of genetic alterations characteristic of the colorectal adenoma–carcinoma sequence does not occur between gastric adenoma and adenocarcinoma

  1995cited by this paper
• Multiple forms of the APC gene transcripts and their tissue-specific expression.

  1993cited by this paper
• Tryptophan-Stoffwechseluntersuchungen bei unbehandelten Phenylketonurikern

  1975cited by this paper

• SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancer

  2025influential citation
• Role of circulating tumor DNA methylation in gastric cancer initiation and progression: A comprehensive review

  2025cites this paper
• lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel.

  2024cites this paper
• Mechanisms of miRNAs (MicroRNAs) and Their Expression in Gastric Cancer.

  2024cites this paper
• Clinical applications and perspectives of circulating tumor DNA in gastric cancer

  2024cites this paper
• Cell-free Nucleic Acid as Promising Diagnostic Biomarkers for Gastric Cancer: a Systematic Review

  2024cites this paper
• Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control Study

  2023cites this paper
• Current status and perspectives of genetic testing in gastrointestinal cancer (Review)

  2023cites this paper
• Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis

  2023cites this paper
• An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer.

  2023cites this paper
• Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer

  2023cites this paper
• Liquid biopsy in gastric cancer: predictive and prognostic biomarkers

  2022cites this paper
• Role of RASSF1-A gene in early detection of colorectal carcinogenesis

  2022influential citation
• Gastric cancer: An epigenetic view

  2022cites this paper
• Correlation between RASSF1A Methylation in Cell-Free DNA and the Prognosis of Cancer Patients: A Systematic Review and Meta-Analysis

  2022cites this paper
• DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer

  2022influential citation
• Molecular and Circulating Biomarkers of Gastric Cancer

  2022cites this paper
• Correlation of RASSF1A gene methylation with gastric cancer and its clinical features: a meta-analysis

  2022cites this paper
• Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients

  2021cites this paper
• Epigenetically inactivated RASSF 1 A as a tumor biomarker

  2021cites this paper
• APC Promoter Methylation in Gastrointestinal Cancer

  2021cites this paper
• Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma

  2021cites this paper
• Recent advances in field effect transistor biosensor technology for cancer detection: a mini review

  2021cites this paper
• Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

  2021cites this paper
• Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives

  2021cites this paper
• Overview of Early Detection of Gastrointestinal Cancer

  2020cites this paper
• RASSF1A: A promising target for the diagnosis and treatment of cancer.

  2020cites this paper
• Methylation Analysis of P16, RASSF1A, RPRM, and RUNX3 in Circulating Cell-Free DNA for Detection of Gastric Cancer: A Validation Study

  2020influential citation
• Association of APC gene promoter methylation and the risk of gastric cancer

  2020influential citation
• Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers

  2020cites this paper
• Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers

  2020cites this paper
• Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities

  2020cites this paper
• Epigenetically inactivated RASSF1A as a tumor biomarker

  2020cites this paper
• Cell-free DNA as a liquid biopsy for early detection of gastric cancer

  2020influential citation
• Circulating cell‐free DNA release in vitro: kinetics, size profiling, and cancer‐related gene methylation

  2019cites this paper
• Cell Biology International

  2019cites this paper
• Circulating tumor DNA RASSF1 methylation for predicting cancer risk: a diagnostic meta-analysis.

  2019cites this paper
• 2D Nanomaterials for Quantitative and Qualitative Analysis of DNA Methylation

  2019cites this paper
• Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients

  2019cites this paper
• Long Noncoding RNA in Preeclampsia: Transcriptional Noise or Innovative Indicators?

  2019cites this paper
• Recent advances in gastric cancer early diagnosis

  2019cites this paper
• Predictive value of the serum RASSF10 promoter methylation status in gastric cancer

  2019cites this paper
• Electrochemical and Optical Biosensing Strategies for DNA Methylation Analysis.

  2019cites this paper
• Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis

  2019cites this paper
• Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.

  2019cites this paper
• Methylation status of RASSF1A associates with prognosis in metastatic gastric cancer

  2019cites this paper
• Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells

  2018cites this paper
• The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers

  2018cites this paper
• Biomarkers of gastric cancer: Current topics and future perspective

  2018cites this paper
• Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers

  2018cites this paper
• MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis

  2018cites this paper
• Evaluation of TAGLN as a diagnostic marker in breast cancer

  2018cites this paper
• Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer

  2018cites this paper
• The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.

  2018cites this paper
• Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?

  2017cites this paper
• RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA

  2017cites this paper
• Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection

  2017cites this paper
• How to stomach an epigenetic insult: the gastric cancer epigenome

  2017cites this paper
• Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives

  2017cites this paper
• Electrochemical biosensing strategies for DNA methylation analysis.

  2017cites this paper
• Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience

  2017cites this paper
• Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis

  2016cites this paper
• Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.

  2016cites this paper
• Methylated circulating tumor DNA in blood: power in cancer prognosis and response

  2016cites this paper
• Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma

  2016cites this paper
• Analysen epigenetischer Marker aus Liquid Biopsies: Informationen von jenseits des Genoms

  2016influential citation
• Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.

  2016cites this paper
• Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

  2016cites this paper
• Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer

  2016influential citation
• Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer

  2016cites this paper
• Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer

  2016cites this paper
• Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis

  2016cites this paper
• Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma.

  2015cites this paper
• Liquid biopsy: will it be the ‘magic tool’ for monitoring response of solid tumors to anticancer therapies?

  2015cites this paper
• Gastric cancer; actualities and perspectives of early diagnosis Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy and targeted therapy

  year unknowncites this paper